MEP38808A - Use of lh in controlled ovarian hyperstimulation - Google Patents

Use of lh in controlled ovarian hyperstimulation

Info

Publication number: MEP38808A
Authority: ME; Montenegro
Prior art keywords: ovarian hyperstimulation; controlled ovarian; coh; controlled; folliculogenesis
Prior art date: 2001-09-12

Application number

MEP-388/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Stephen Hillier

Colin Michael Howles

Original Assignee

Merck Serono Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-12

Filing date

2002-09-12

Publication date

2011-02-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP38808(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-12 Application filed by Merck Serono Sa filed Critical Merck Serono Sa

2011-02-10 Publication of MEP38808A publication Critical patent/MEP38808A/xx

Links

206010033266 Ovarian Hyperstimulation Syndrome Diseases 0.000 title abstract 2
230000000694 effects Effects 0.000 abstract 1
230000002045 lasting effect Effects 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MEP-388/08A 2001-09-12 2002-09-12 Use of lh in controlled ovarian hyperstimulation MEP38808A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01307755		2001-09-12
PCT/GB2002/004147 WO2003022301A2 (en)	2001-09-12	2002-09-12	Use of lh in controlled ovarian hyperstimulation

Publications (1)

Publication Number	Publication Date
MEP38808A true MEP38808A (en)	2011-02-10

Family

ID=8182260

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-388/08A MEP38808A (en)	2001-09-12	2002-09-12	Use of lh in controlled ovarian hyperstimulation

Country Status (27)

Country	Link
US (1)	US7341989B2 (pl)
EP (1)	EP1434600B1 (pl)
JP (1)	JP2005504072A (pl)
KR (1)	KR20040032953A (pl)
CN (1)	CN1302806C (pl)
AR (1)	AR036591A1 (pl)
AT (1)	ATE427755T1 (pl)
AU (1)	AU2002331939B2 (pl)
BR (1)	BR0212502A (pl)
CA (1)	CA2457067A1 (pl)
CY (1)	CY1110487T1 (pl)
DE (1)	DE60231892D1 (pl)
DK (1)	DK1434600T3 (pl)
EA (1)	EA009210B1 (pl)
ES (1)	ES2322136T3 (pl)
HR (1)	HRP20040070A2 (pl)
IL (1)	IL160781A0 (pl)
ME (1)	MEP38808A (pl)
MX (1)	MXPA04002125A (pl)
NO (1)	NO327154B1 (pl)
PL (1)	PL205472B1 (pl)
PT (1)	PT1434600E (pl)
RS (1)	RS51505B (pl)
SI (1)	SI1434600T1 (pl)
UA (1)	UA78970C2 (pl)
WO (1)	WO2003022301A2 (pl)
ZA (1)	ZA200401008B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1684737A (zh) *	2002-06-07	2005-10-19	阿雷斯贸易股份有限公司	控制性超排卵方法及该方法使用的药物试剂盒
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
CN102296047B (zh) *	2011-08-13	2013-03-13	新疆农垦科学院	利用羔羊超排卵母细胞生产体外胚胎的方法
US20150272622A1 (en)	2011-12-22	2015-10-01	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
US9282995B2 (en) *	2011-12-22	2016-03-15	Previvo Genetics, Llc	Recovery and processing of human embryos formed in vivo
US9216037B2 (en)	2013-06-21	2015-12-22	Previvo Genetics, Llc	Uterine lavage for embryo retrieval
US20160024181A1 (en)	2013-03-13	2016-01-28	Moderna Therapeutics, Inc.	Long-lived polynucleotide molecules
RU2629871C1 (ru) *	2016-03-22	2017-09-04	Сергей Михайлович Юдин	Препарат для стимуляции фолликулогенеза и способ его применения
IT202000022015A1 (it) *	2020-09-18	2022-03-18	Marca Antonio La	Nuovo uso dell'ormone luteinizzante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4589402A (en)	1984-07-26	1986-05-20	Serono Laboratories, Inc.	Method of in vitro fertilization
IT1250075B (it) *	1991-12-18	1995-03-30	Serono Cesare Ist Ricerca	Composizioni farmaceutiche contenenti gonadotropine.
CA2372714A1 (en) *	1999-05-07	2000-11-16	Stephen Franks	The use of luteinizing hormone in the induction of pauci-or unifolliculogenesis

2002
- 2002-09-12 SI SI200230815T patent/SI1434600T1/sl unknown
- 2002-09-12 ES ES02767637T patent/ES2322136T3/es not_active Expired - Lifetime
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/es active IP Right Grant
- 2002-09-12 AT AT02767637T patent/ATE427755T1/de active
- 2002-09-12 AR ARP020103455A patent/AR036591A1/es not_active Application Discontinuation
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/ko not_active Ceased
- 2002-09-12 RS YUP-212/04A patent/RS51505B/sr unknown
- 2002-09-12 DE DE60231892T patent/DE60231892D1/de not_active Expired - Lifetime
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-09-12 CN CNB028175743A patent/CN1302806C/zh not_active Expired - Fee Related
- 2002-09-12 IL IL16078102A patent/IL160781A0/xx unknown
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/xx unknown
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/ja active Pending
- 2002-09-12 EA EA200400428A patent/EA009210B1/ru not_active IP Right Cessation
- 2002-09-12 DK DK02767637T patent/DK1434600T3/da active
- 2002-09-12 PL PL367343A patent/PL205472B1/pl unknown
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/pt not_active Application Discontinuation
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 PT PT02767637T patent/PT1434600E/pt unknown
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en not_active Ceased
- 2002-09-12 HR HR20040070A patent/HRP20040070A2/hr not_active Application Discontinuation
- 2002-12-09 UA UA2004031858A patent/UA78970C2/uk unknown
2004
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/no not_active IP Right Cessation
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/el unknown

Also Published As

Publication number	Publication date
KR20040032953A (ko)	2004-04-17
PL205472B1 (pl)	2010-04-30
AU2002331939B2 (en)	2007-10-25
YU21204A (sh)	2006-08-17
WO2003022301A2 (en)	2003-03-20
DK1434600T3 (da)	2009-05-25
WO2003022301A3 (en)	2003-04-17
HRP20040070A2 (en)	2004-10-31
US7341989B2 (en)	2008-03-11
JP2005504072A (ja)	2005-02-10
IL160781A0 (en)	2004-08-31
PL367343A1 (pl)	2005-02-21
ZA200401008B (en)	2005-08-31
ATE427755T1 (de)	2009-04-15
ES2322136T3 (es)	2009-06-17
EA009210B1 (ru)	2007-12-28
CN1553809A (zh)	2004-12-08
HK1067866A1 (en)	2005-04-22
AR036591A1 (es)	2004-09-22
MXPA04002125A (es)	2004-07-08
EP1434600A2 (en)	2004-07-07
SI1434600T1 (sl)	2009-06-30
CA2457067A1 (en)	2003-03-20
RS51505B (sr)	2011-06-30
CN1302806C (zh)	2007-03-07
BR0212502A (pt)	2004-08-24
UA78970C2 (uk)	2007-05-10
CY1110487T1 (el)	2015-04-29
US20050049199A1 (en)	2005-03-03
EP1434600B1 (en)	2009-04-08
DE60231892D1 (de)	2009-05-20
NO327154B1 (no)	2009-05-04
PT1434600E (pt)	2009-04-28
NO20040990L (no)	2004-03-08
EA200400428A1 (ru)	2004-08-26

Similar Documents

Publication	Publication Date	Title
UA42747C2 (uk)	2001-11-15	Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
BR9106702A (pt)	1993-06-08	Analogo de oligonucleotideos e processos para modular a producao de uma proteina por um organismo e para tratar um organismo
BR9006729A (pt)	1991-08-06	Dispositivo de reforco e de sustentacao da capa dos rotadores de uma articulacao de ombro humano
HUP0003349A2 (hu)	2001-01-29	Mellékpajzsmirigy-hormon peptidanalógok, ezeket hatóanyagként tartalmazó gyógyászati készítmények és alkalmazásuk
DE69839812D1 (de)	2008-09-11	Analoge des menschlichen interferon-alpha mit niedriger toxizität
ATE322280T1 (de)	2006-04-15	Verwendung von daptomycin
NO952744D0 (no)	1995-07-11	Cytokinbegrensende midler
BR9906796A (pt)	2000-11-14	Método para a administração de análogos de insulina monoméricos
DE69825048D1 (de)	2004-08-19	Analoga von duocarmycin and cc-1065
ATE192037T1 (de)	2000-05-15	Verwendung von arginin als immunstimulator
KR950031060A (ko)	1995-12-18	골다공증 치료용 약제학적 조성물
DK1473040T3 (da)	2010-03-15	Anvendelse af humant parathyroidhormon
CY1110487T1 (el)	2015-04-29	Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων
DE69814109D1 (de)	2003-06-05	1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DK0678013T3 (da)	1997-05-26	Præparater til behandling af hår
EA201000386A1 (ru)	2011-06-30	Нетоксичные для нервной ткани плазминоген-активирующие факторы для лечения инсульта
ES2135398T3 (es)	1999-11-01	Compuesto y composiciones de inhibicion de la resorcion osea.
DE69630583D1 (de)	2003-12-11	Peptide, bronchodilator und den blutstrom verbesserndes mittel
ATE398134T1 (de)	2008-07-15	Neue analoga von nitrobenzylthioinosin
ATE433749T1 (de)	2009-07-15	Neue verwendung von rapamycin und strukturellen analoga hiervon
ATE374202T1 (de)	2007-10-15	Neue analoga von nitrobenzylthioinosin
DK1007085T3 (da)	2002-05-13	Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
EA201000501A1 (ru)	2010-10-29	Фармацевтическая композиция, содержащая не обладающий нейротоксичностью активатор плазминоген для лечения удара
GB9015774D0 (en)	1990-09-05	Novel treatment
DK1707568T3 (da)	2010-11-08	Farmaceutisk sammensætning til anvendelse i behandlingen af ovariecancer hos et menneske, der har sygdommen